FFAGLDD
This MMP9-cleavable peptide, FFAGLDD, enables the cytosolic delivery of Doxorubicin for controlled spatiotemporal drug release. It is used in research for targeted cancer therapy, facilitating studies on MMP9-responsive drug delivery systems in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Protein Biochemistry
Molecular Weight
783.82
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
